Usha K. Nivarthi - Concepedia

Author

Usha K. Nivarthi

University of North Carolina at Chapel Hill ORCID

Also Known As

Marcet, Stephanie, Moser J, Nivarthi, Usha, Swanstrom, Jesica A., U Nivarthi, U. Nivarthi, Usha K Nivarthi, Usha K. Nivarthi, Usha Nivarthi, Weiskopf, Daniela

Publications

528

Citations

H-Index

Concepts

All Affiliations

University of North Carolina at Chapel Hill Johns Hopkins University National Institutes of Health National Institute of Allergy and Infectious Diseases Victorian Infectious Diseases Reference Laboratory

About

Usha K. Nivarthi is an author at University of North Carolina at Chapel Hill specializing in vaccination, hepatitis, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	44
2	Immunology	2	2	44
3	Autoimmunity	1	1	16
4	Immunodominance	1	1	16
5	T Cell Immunity	1	1	28

Usha K. Nivarthi

Publications

526

Citations

H-Index

Page 1

	Year	Citations
Genetic Variation between Dengue Virus Type 4 Strains Impacts Human Antibody Binding and Neutralization Emily N. Gallichotte, Thomas J. Baric, Usha K. Nivarthi, Cell Reports	2018	75
High Rates of Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection in People Who Inject Drugs: A Prospective Cohort Study Rachel Sacks‐Davis, Campbell Aitken, Peter Higgs, PLoS ONE	2013	69
A tetravalent live attenuated dengue virus vaccine stimulates balanced immunity to multiple serotypes in humans Usha K. Nivarthi, Jesica Swanstrom, Matthew J. Delacruz, Nature Communications	2021	69
Antigenic Variation of the Dengue Virus 2 Genotypes Impacts the Neutralization Activity of Human Antibodies in Vaccinees David R. Martinez, Boyd L. Yount, Usha K. Nivarthi, Cell Reports	2020	60
Dengue Virus prM-Specific Human Monoclonal Antibodies with Virus Replication-Enhancing Properties Recognize a Single Immunodominant Antigenic Site Scott A. Smith, Usha K. Nivarthi, Ruklanthi de Alwis, Journal of Virology	2015	53
Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination Usha K. Nivarthi, Nurgun Kose, Gopal Sapparapu, Journal of Virology	2016	51
Longitudinal analysis of acute and convalescent B cell responses in a human primary dengue serotype 2 infection model Usha K. Nivarthi, Huy A. Tu, Matthew J. Delacruz, EBioMedicine	2019	33
Antigen-Driven Patterns of TCR Bias Are Shared across Diverse Outcomes of Human Hepatitis C Virus Infection John J. Miles, Duangtawan Thammanichanond, Sarah Moneer, The Journal of Immunology VaccinationHepatitis CAdaptive Immune SystemViral HepatitisAntigen-driven Patterns	2010	28
Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines Jesica Swanstrom, Usha K. Nivarthi, B. L. Patel, The Journal of Infectious Diseases	2019	27
Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4 Douglas G. Widman, Ellen Young, Usha K. Nivarthi, Scientific Reports	2017	24

Page 1